Frailty in Patient Undergoing Percutaneous Left Atrial Appendage Closure.

Launched by JOSEP RODES-CABAU · Feb 22, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how frailty affects patients who are undergoing a specific heart procedure called Left Atrial Appendage Closure (LAAC). Frailty generally means being weaker or more vulnerable, which can impact recovery and quality of life. The study aims to understand how common frailty is among patients having this procedure and how it relates to their recovery and long-term health outcomes.

If you are at least 18 years old and are planning to have the LAAC procedure with an approved device, you may be eligible to participate. However, you cannot join if you have severe mental health issues or are unable to give consent. Participants in this trial will help researchers gather important information that could improve care for future patients. Overall, the study seeks to find out how frailty affects both the immediate results of the procedure and the patients' overall well-being in the long run.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Transcatheter LAAC with any approved device
• • Age ≥18 years old
• Exclusion Criteria:
• • Unable to provide informed consent
• • Severe neuropsychiatric impairment